Pictet Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $179K | Hold |
35,397
| – | – | ﹤0.01% | 1851 |
|
|
2025
Q1 | $187K | Hold |
35,397
| – | – | ﹤0.01% | 1808 |
|
|
2024
Q4 | $239K | Buy |
35,397
+13,066
| +59% | +$88.3K | ﹤0.01% | 1768 |
|
|
2024
Q3 | $147K | Hold |
22,331
| – | – | ﹤0.01% | 1897 |
|
|
2024
Q2 | $167K | Hold |
22,331
| – | – | ﹤0.01% | 1800 |
|
|
2024
Q1 | $223K | Buy |
22,331
+7,344
| +49% | +$73.2K | ﹤0.01% | 1716 |
|
|
2023
Q4 | $148K | Hold |
14,987
| – | – | ﹤0.01% | 1807 |
|
|
2023
Q3 | $115K | Buy |
+14,987
| New | +$115K | ﹤0.01% | 1810 |
|